175 related articles for article (PubMed ID: 36585164)
1. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
[TBL] [Abstract][Full Text] [Related]
2. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
3. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
Meng C; Zhang Y; Jiang D; Wang J
World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
[TBL] [Abstract][Full Text] [Related]
4. CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma.
Zhong R; Yang M; Zhu R; Zhang J; Wang L
Oncol Lett; 2023 Apr; 25(4):133. PubMed ID: 36909370
[TBL] [Abstract][Full Text] [Related]
5. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
8. CTHRC1 promotes gastric cancer metastasis via HIF-1α/CXCR4 signaling pathway.
Ding X; Huang R; Zhong Y; Cui N; Wang Y; Weng J; Chen L; Zang M
Biomed Pharmacother; 2020 Mar; 123():109742. PubMed ID: 31855733
[TBL] [Abstract][Full Text] [Related]
9. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
10. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
11. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
Zhu C; Xiao D
Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis reveals
Zhu Z; Xu J; Li L; Ye W; Chen B; Zeng J; Huang Z
Transl Cancer Res; 2020 Jul; 9(7):4093-4110. PubMed ID: 35117779
[TBL] [Abstract][Full Text] [Related]
13. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
14. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.
Sial N; Ahmad M; Hussain MS; Iqbal MJ; Hameed Y; Khan M; Abbas M; Asif R; Rehman JU; Atif M; Khan MR; Hameed Z; Saeed H; Tanveer R; Saeed S; Sharif A; Asif HM
Sci Rep; 2021 Oct; 11(1):19873. PubMed ID: 34615943
[TBL] [Abstract][Full Text] [Related]
15. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
16. Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database.
Liu B; Chen L; Huang H; Huang H; Jin H; Fu C
Dis Markers; 2022; 2022():7803642. PubMed ID: 35756485
[TBL] [Abstract][Full Text] [Related]
17. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
18. CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer.
Wang Z; Zhang S; Zheng C; Xia K; Sun L; Tang X; Zhou F; Ouyang Y; Tang F
Int J Gen Med; 2022; 15():5701-5713. PubMed ID: 35755862
[TBL] [Abstract][Full Text] [Related]
19. Cthrc1 overexpression is an independent prognostic marker in gastric cancer.
Gu L; Liu L; Zhong L; Bai Y; Sui H; Wei X; Zhang W; Huang P; Gao D; Kong Y; Lou G
Hum Pathol; 2014 May; 45(5):1031-8. PubMed ID: 24746208
[TBL] [Abstract][Full Text] [Related]
20. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.
Wang P; Wang YC; Chen XY; Shen ZY; Cao H; Zhang YJ; Yu J; Zhu JD; Lu YY; Fang JY
Cancer Sci; 2012 Jul; 103(7):1327-33. PubMed ID: 22590977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
